Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Muus

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Advances in Experimental Medicine and Biology|September 29, 1999
New developments in the treatment of acute myeloid leukemiaM Smeets, T de Witte, N van der Lely, et al.
Leukemia & Lymphoma|December 29, 1999
Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemiaS Jerjis, S Croockewit, P Muus, et al.
Bone Marrow Transplantation|January 1, 1993
Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugationT De Witte, A Schattenberg, F Preijers, et al.
Seminars in Oncology|June 1, 1987
Influence of dose and duration of exposure on the cytotoxic effect of cytarabine toward human hematopoietic clonogenic cellsP Muus, C Haanen, R Raijmakers, et al.
Bone Marrow Transplantation|June 1, 1992
A scheme for daily monitoring of oral mucositis in allogeneic BMT recipientsJ P Donnelly, P Muus, A Schattenberg, et al.
Experimental Hematology|May 1, 1991
Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cellsN Van Der Lely, T De Witte, P Muus, et al.
Journal of Thrombosis and Haemostasis : JTH|September 3, 2015
Neutrophil activation and nucleosomes as markers of systemic inflammation in paroxysmal nocturnal hemoglobinuria: effects of eculizumabS T A van Bijnen, D Wouters, G J van Mierlo, et al.
Seminars in Oncology|December 1, 1993
Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependentP Muus, P Donnelly, A Schattenberg, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1993
Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipientsJ P Donnelly, P Muus, A M Horrevorts, et al.
British Journal of Cancer|July 1, 1991
1-beta-D-arabinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukaemic cellsP Muus, C Van den Bogert, H De Vries, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|September 29, 1999
New developments in the treatment of acute myeloid leukemiaM Smeets, T de Witte, N van der Lely, et al.
Leukemia & Lymphoma|December 29, 1999
Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemiaS Jerjis, S Croockewit, P Muus, et al.
Bone Marrow Transplantation|January 1, 1993
Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugationT De Witte, A Schattenberg, F Preijers, et al.
Seminars in Oncology|June 1, 1987
Influence of dose and duration of exposure on the cytotoxic effect of cytarabine toward human hematopoietic clonogenic cellsP Muus, C Haanen, R Raijmakers, et al.
Bone Marrow Transplantation|June 1, 1992
A scheme for daily monitoring of oral mucositis in allogeneic BMT recipientsJ P Donnelly, P Muus, A Schattenberg, et al.
Experimental Hematology|May 1, 1991
Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cellsN Van Der Lely, T De Witte, P Muus, et al.
Journal of Thrombosis and Haemostasis : JTH|September 3, 2015
Neutrophil activation and nucleosomes as markers of systemic inflammation in paroxysmal nocturnal hemoglobinuria: effects of eculizumabS T A van Bijnen, D Wouters, G J van Mierlo, et al.
Seminars in Oncology|December 1, 1993
Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependentP Muus, P Donnelly, A Schattenberg, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1993
Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipientsJ P Donnelly, P Muus, A M Horrevorts, et al.
British Journal of Cancer|July 1, 1991
1-beta-D-arabinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukaemic cellsP Muus, C Van den Bogert, H De Vries, et al.
Pageof 7